Lactation Lowers Risk of T2DM After Gestational Diabetes
THURSDAY, April 5, 2018 -- For women with previous gestational diabetes mellitus (GDM), lactation is associated with reduced risk of type 2 diabetes mellitus (T2DM), although there is no benefit for long-term lactation, according to a review and meta-analysis published online March 25 in the Journal of Diabetes Investigation.
Lijun Feng, from Zhejiang University in Hangzhou, China, and colleagues conducted a systematic review to examine the effect of lactation on the development of T2DM in women with prior GDM. The meta-analysis included 13 cohort studies.
The researchers found that lactation was significantly associated with a lower risk of T2DM compared with no lactation (relative risk, 0.66; 95 percent confidence interval, 0.48 to 0.90; P < 0.001). This correlation was prominent in studies conducted in the United States (relative risk, 0.66; 95 percent confidence interval, 0.43 to 0.99), regardless of study design, smaller sample size, follow-up duration greater than one year, and use of adjusted data. By pooling data from three studies, long-term lactation (more than one to three months postpartum) was not associated with T2DM risk compared with no lactation (relative risk, 0.69; 95 percent confidence interval, 0.41 to 1.17).
"This meta-analysis demonstrated that lactation was associated with a lower risk of T2DM in women with prior GDM," the authors write. "Further, no significant relationship between long-term lactation and T2DM risk was detected."
© 2020 HealthDay. All rights reserved.
Posted: April 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.